Edition:
United States

Aetna Inc (AET)

AET on New York Consolidated

122.31USD
13 Jan 2017
Change (% chg)

$-0.33 (-0.27%)
Prev Close
$122.64
Open
$122.78
Day's High
$123.13
Day's Low
$122.11
Volume
2,784,944
Avg. Vol
2,605,680
52-wk High
$136.50
52-wk Low
$92.42

Select another date:

Fri, Jan 6 2017

Photo

J&J, Actelion approach Swiss takeover board over deal structure: paper

ZURICH Johnson & Johnson and Actelion have asked Switzerland's takeover board about the viability of a complicated takeover deal the U.S. healthcare company is discussing with the Swiss biotech firm, newspaper Tages-Anzeiger reported on Friday, without saying how it got the information.

J&J, Actelion approach Swiss takeover board over deal structure -paper

ZURICH, Jan 6 Johnson & Johnson and Actelion have asked Switzerland's takeover board about the viability of a complicated takeover deal the U.S. healthcare company is discussing with the Swiss biotech firm, newspaper Tages-Anzeiger reported on Friday, without saying how it got the information.

Gilead poaches Novartis cancer specialist Riva

ZURICH Gilead Sciences has hired a top cancer specialist from Swiss drugmaker Novartis as the U.S. healthcare group sharpens its focus on oncology.

U.S. seeks to undercut Aetna CEO's defense in merger fight

WASHINGTON The U.S. Justice Department sought on Monday to knock down arguments by Aetna Inc's chief executive that Medicare Advantage competes with government insurance programs, making Aetna's proposed merger with Humana legal under antitrust law. Aetna CEO Mark Bertolini testified on Friday and returned to the witness stand Monday morning. The Justice Department sued to stop the merger in July.

Aetna CEO defends merger with Humana in antitrust trial

WASHINGTON Aetna Inc's chief executive denied on Friday that its withdrawal from some Obamacare exchanges was in retaliation for government efforts to halt its merger with Humana Inc , as he sought to convince a federal judge to approve the deal. The U.S. Justice Department sued to stop the $34 billion tie-up in July, saying that it and another insurance mega merger, Anthem Inc's planned purchase of Cigna Corp , would mean higher

U.S. attorneys argue Aetna-Humana deal violates antitrust law

WASHINGTON A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks.

Novartis CEO plays down prospects for Actelion bid: Blick

VIENNA Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction.

Actelion shares plunge on report it eyes 'complicated' J&J deal

ZURICH Shares in Swiss biotech company Actelion plunged on Tuesday after a report the company was not actively considering selling itself, but instead weighing a "complicated deal" to link with U.S. healthcare giant Johnson & Johnson .

Actelion shares plunge on report it eyes "complicated" J&J deal

ZURICH, Nov 29 Shares in Swiss biotech company Actelion plunged on Tuesday after a report the company was not actively considering selling itself, but instead weighing a "complicated deal" to link with U.S. healthcare giant Johnson & Johnson.

J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg

Nov 24 U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter.

Select another date: